-
LamotrigineCAS No.: 84057-84-1. Molecular Formula: C9H7Cl2N5. Molecular Weight: 256.09 g/molread more
-
AnastrozoleAPI: Anastrozole CAS No:120511-73-1 Therapeutic Category: Aromatase inhibitors Specification:ChP, USP DMF Status: Ready DMF Certification: GMP Availability:Ready stockread more
-
Potassium Guaiacol SulfonateAPI:Potassium Guaiacol Sulfonate CAS NO:1321-14-8 Therapeutic Category:Expectorant drug Specification:USP latest DMF:USDMF, EDMF Certification:GMP, KFDA Availability:Regularly availableread more
-
PyrazinamidePyrazinamide (PZA) is an antimicrobial agent that is most commonly used for treatment of active tuberculosis (TB) during the initial phase of therapy (generally the first two months of treatment), inread more
-
UbrogepantCAS Registry Number: 953762-84-8. Molecular Formula: C29H26F6N6O3. Molecular Weight: 624.55 g/molread more
-
Memantine HydrochlorideCAS No. 41100-52-1. Molecular Formula: C12H21N.HCl. Molecular Weight: 215.76 g/molread more
-
AripiprazoleCAS Number: 129722-12-9. Molecular Formula: C23H27Cl2N3O2. Molecular Weight: 448.38 g/mol (Free base)read more
-
Moxifloxacin HydrochlorideCAS No. 186826-86-8. Molecular Formula: C21H24FN3O4 · HCl. Molecular Weight: 437.90 g/molread more
-
Valacyclovir HydrochlorideCAS No. 124832-27-5. Molecular Formula: C13H20N6O4·HCl. Molecular Weight: 360.80 g/molread more
-
EnzalutamideAPI:Enzalutamide CAS NO:915087-33-1 Therapeutic Category:Anti-cancer Availability:Under developmentread more
WebData synthesis: Across phase IIb and phase III clinical trials, abrocitinib was efficacious with an average of 47.5% patients on 200 mg abrocitinib and 32.0% on 100 mg...
Webhave abnormal blood tests (low platelet count or white blood cell count) have any eye problems, including cataracts or retinal detachment have recently received or are...
WebFeb 8, 2022 · Abrocitinib is a white to pale colored powder with the following chemical name: N-((1s,3s)-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1...
WebAbrocitinib is used to treat moderate to severe eczema (atopic dermatitis; a skin disease that causes the skin to be dry and itchy and to sometimes develop red, scaly rashes) in...
WebBACKGROUND: Abrocitinib, an oral Janus kinase 1 inhibitor, provided significant itch relief by week 2 in patients with moderate-to-severe atopic dermatitis (AD) in the phase III...
Web(abrocitinib ) tablets, for oral use Initial U.S. Approval: 2022 . WARNING: SERIOUS INFECTIONS, MORTALITY, • MALIGNANCY, MAJOR ADVERSE CARDIOVASCULAR...
